Mahamaya Lifesciences Limited, incorporated in 2002, is engaged in providing high-quality Agriculture Crop Protection Solutions through manufacturing and supply of pesticide formulations. It earns revenue from both domestic sales and exports of agrochemicals, supplying to Indian agrochemical firms and multinational corporations (MNCs). The company also imports essential technical molecules not manufactured in India, formulates them domestically, and markets value-added products.

Mahamaya Lifesciences, an Book Built Issue, amounting to â‚¹ 70.44 Crore, consisting an fresh issue of 0.56 crore shares aggregating to ₹64.28 crores and offer for sale of 0.05 crore shares aggregating to ₹6.16 crores. Mahamaya Lifesciences IPO opens on November 11, 2025, and closes on November 13, 2025. The allotment is expected to be finalized on or about Friday, November 14, 2025, and the shares will be listed on the BSE SME with a tentative listing date set on or about Tuesday, November 18 2025.

The Share Price Band of Mahamaya Lifesciences IPO is set at â‚¹ 108 to ₹ 114 per equity share. The Market Capitalisation of the Mahamaya Lifesciences at IPO price of ₹ 114 per equity share will be  â‚¹ 266.82 Crores. The lot size of the IPO is 1,200 shares. Retail investors are required to invest a minimum of  â‚¹ 273,600 ( 2,400 shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is 3 lots ( 3,600 shares), amounting to â‚¹ 4,10,400.

 Oneview Corporate Advisors Pvt.Ltd. are the book running lead manager of the Mahamaya Lifesciences, while Kfin Technologies Ltd. is the registrar for the issue. The Market Maker of the company is Mansi Share & Stock Broking Pvt.Ltd.

Mahamaya Lifesciences Limited IPO GMP Today
The Grey Market Premium of Mahamaya Lifesciences IPO is expected to be â‚¹ 0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Mahamaya Lifesciences Limited IPO Live Subscription Status Today: Real-Time Update 

As of 06:30 PM on 13 November, 2025, the Mahamaya Lifesciences IPO live subscription status shows that the IPO subscribed 1.59 times on its Final Day of subscription period. Check the Mahamaya Lifesciences IPO Live Subscription Status Today at BSE.

Mahamaya Lifesciences Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Mahamaya Lifesciences IPO allotment date is 14 November, 2025, Friday. Mahamaya Lifesciences IPO Allotment will be out on 14 November, 2025, Friday and will be live on Registrar Website from the allotment date.
Check Kfin Technologies Ltd. IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Mahamaya Lifesciences IPO from the dropdown list of IPOs
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Mahamaya Lifesciences Limited IPO
Mahamaya Lifesciences to utilise the Net Proceeds towards the following objects: 
1. â‚¹ 375.34 Lakhs is required for Purchase of Equipment for existing Formulation plant. 
2. â‚¹ 2942.35 Lakhs is required for Funding capital expenditure towards setting up of a new technical manufacturing plant.
3. ₹ 252.53 Lakhs is required for Construction of Warehouse Building and Purchase of Machinery.
4. â‚¹ 1,800 Lakhs is required for Funding working capital requirement of our Company.
5. General Corporate Expenses.

Refer to Mahamaya Lifesciences Limited RHP for more details about the Company.